Top 5 Stocks to Buy Now
→ Read now. Do not delete. You’ve been warned. (From Porter & Company) (Ad)tc pixel Free DMRA Stock Alerts

Damora Therapeutics, Inc. Common Stock (DMRA) Short Interest Ratio & Short Volume

Damora Therapeutics, Inc. Common Stock logo
$25.21 +2.64 (+11.70%)
As of 06/26/2026 03:57 PM Eastern
Compare

Damora Therapeutics, Inc. Common Stock Short Interest Overview

As of June 15, 2026, Damora Therapeutics, Inc. Common Stock (DMRA) had a short interest of 1.31 million shares sold short, representing 2.14% of the public float. This marks a -6.60% decrease in short interest since the prior report. The short interest ratio (days to cover) is 3.4, meaning it would take 3.4 days of the average trading volume of 463,273 shares to cover all short positions.

Current Short Interest
1,310,364 shares
Previous Short Interest
1,402,988 shares
Change Vs. Previous Month
-6.60%
Dollar Volume Sold Short
$26.30 million
Short Interest Ratio
3.4 Days to Cover
Last Record Date
June 15, 2026
Outstanding Shares
61,550,000 shares
Short Percent of Float
2.14%
Today's Trading Volume
8,623,760 shares
Average Trading Volume
463,273 shares
Today's Volume Vs. Average
1,861%
Short Selling Damora Therapeutics, Inc. Common Stock?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Damora Therapeutics, Inc. Common Stock and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

DMRA Short Interest Over Time

DMRA Days to Cover Over Time

DMRA Percentage of Float Shorted Over Time

Damora Therapeutics, Inc. Common Stock Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/20261,310,364 shares $26.30 million -6.6%2.1%3.37 $20.07
5/29/20261,402,988 shares $34.91 million +8.7%2.3%4.14 $24.88
5/15/20261,290,741 shares $31.75 million +8.4%2.1%3.09 $24.60
4/30/20261,191,070 shares $30.56 million +6.7%2.0%5.51 $25.66
4/15/20261,116,620 shares $29.71 million +35.0%1.8%4.72 $26.61
3/31/2026827,221 shares $21.43 million +93.4%1.3%2.46 $25.90
3/13/2026427,713 shares $12.19 million +31.6%0.8%1.94 $28.50
2/27/2026325,076 shares $9.62 million +17.4%22.7%1.13 $29.58
2/13/2026277,004 shares $8.07 million +86.6%19.4%0.6 $29.12
1/30/2026148,474 shares $3.90 million -12.3%10.4%4.56 $26.24
1/15/2026169,350 shares $4.06 million -1.8%11.8%6.28 $23.95
12/31/2025172,444 shares $3.97 million -4.8%12.1%2.31 $23.01
12/15/2025181,086 shares $5.72 million +8.1%12.7%1.15 $31.60
11/28/2025167,465 shares $2.90 million -50.4%14.1%0.8 $17.35
11/14/2025337,430 shares $9.05 million +920.8%28.5%0.05 $26.83
10/31/202533,054 shares $241.96 thousand -62.9%2.8%0.33 $7.32
10/15/202589,100 shares $1.04 million -32.1%7.1%0 $11.68
9/30/2025131,200 shares $488.06 thousand +57.7%11.3%0.1 $3.72
9/15/202583,200 shares $235.46 thousand +560.3%7.3%0.1 $2.83
8/31/202512,600 shares $40.02 thousand -34.4%1.1%0.1 $3.18
8/15/202519,200 shares $65.38 thousand -30.2%1.7%0.9 $3.41
7/31/202527,500 shares $90.61 thousand -30.6%2.4%0.6 $3.30
7/15/202539,600 shares $140.58 thousand +7.3%3.5%0.9 $3.55
6/30/202536,900 shares $125.83 thousand -18.0%3.2%0.8 $3.41
6/15/202545,000 shares $150.75 thousand -40.4%4.0%0.5 $3.35
5/31/202575,500 shares $234.81 thousand +36.3%6.6%0.3 $3.11
5/15/202555,400 shares $161.21 thousand -20.4%4.9%0.2 $2.91
4/30/202569,600 shares $194.88 thousand +20.8%6.1%0.3 $2.80
4/15/202557,600 shares $148.03 thousand -11.0%5.1%0.2 $2.57
3/31/202564,700 shares $200.57 thousand +133.6%5.7%0.3 $3.10
3/15/202527,700 shares $112.19 thousand +51.4%2.4%0.1 $4.05
2/28/202518,300 shares $80.15 thousand -10.3%1.6%1 $4.38
2/15/202520,400 shares $97.51 thousand +56.9%1.8%1 $4.78
1/31/202513,000 shares $65 thousand -27.4%1.1%0.7 $5.00
1/15/202517,900 shares $86.28 thousand +6.6%1.6%0.9 $4.82
12/31/202416,800 shares $78.12 thousand -30.9%1.5%0.8 $4.65
12/15/202424,300 shares $123.44 thousand +20.3%2.1%0.9 $5.08
11/30/202420,200 shares $107.06 thousand +112.6%1.8%0.7 $5.30
11/15/20249,500 shares $60.42 thousand +97.9%0.8%0.2 $6.36
10/31/20244,800 shares $32.88 thousand -48.9%0.4%0.1 $6.85
Iran War Shock: What I Was Told In That Private Meeting (Ad)

You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel

Because THIS is the real reason.
10/15/20249,400 shares $63.26 thousand -36.1%0.9%0.3 $6.73
9/30/202414,700 shares $178.61 thousand +129.7%1.4%0.5 $12.15
9/15/20246,400 shares $82.75 thousand -62.1%0.6%0.3 $12.93
8/31/202416,900 shares $201.96 thousand +98.8%1.9%1 $11.95
8/15/20248,500 shares $4.68 thousand +3.7%0.0%0.1 $0.55
7/31/20248,200 shares $4.62 thousand +173.3%0.0%0.1 $0.56
7/15/20243,000 shares $1.77 thousand -90.3%0.0%0 $0.59
6/30/202430,800 shares $14.61 thousand +1,084.6%0.2%0.2 $0.47
6/15/20242,600 shares $1.38 thousand -72.0%0.0%0 $0.53
5/31/20249,300 shares $5.65 thousand -80.4%0.1%0.1 $0.61
5/15/202447,400 shares $30.14 thousand -44.4%0.2%0.3 $0.64
4/30/202485,300 shares $58.77 thousand +373.9%0.4%0.4 $0.69
4/15/202418,000 shares $12.37 thousand -42.9%0.1%0.1 $0.69
3/31/202431,500 shares $24.57 thousand +74.0%0.2%0.1 $0.78
3/15/202418,100 shares $14.80 thousand -66.9%0.1%0 $0.82
2/29/202454,600 shares $39.32 thousand +39.6%0.3%0.1 $0.72
2/15/202439,100 shares $26.60 thousand -40.5%0.2%0.1 $0.68
1/31/202465,700 shares $40.21 thousand -53.0%0.3%0.2 $0.61
1/15/2024139,800 shares $96.18 thousand -54.3%0.7%0.4 $0.69
12/31/2023306,000 shares $220.32 thousand +332.2%1.6%0.8 $0.72
12/15/202370,800 shares $43.05 thousand -61.4%0.4%0.1 $0.61
11/30/2023183,400 shares $115.54 thousand -26.1%1.0%0.4 $0.63
11/15/2023248,000 shares $152.05 thousand -46.5%1.3%0.5 $0.61
10/31/2023463,900 shares $245.91 thousand -32.6%2.4%0.7 $0.53
10/15/2023688,500 shares $425.15 thousand -53.8%3.5%0.9 $0.62
9/30/20231,490,000 shares $1.07 million +337.5%7.0%2 $0.72
9/15/2023340,600 shares $201.87 thousand +95.8%1.6%0.7 $0.59
8/31/2023174,000 shares $105.27 thousand -55.9%0.8%0.4 $0.61
8/15/2023394,500 shares $265.70 thousand +73.0%2.0%1 $0.67
7/31/2023228,100 shares $702.55 thousand +403.5%1.2%1.3 $3.08
7/15/202345,300 shares $108.72 thousand -4.0%0.3%0.4 $2.40
6/30/202347,200 shares $118.94 thousand +271.7%0.3%0.7 $2.52
6/15/202312,700 shares $27.94 thousand +4.1%0.1%0.2 $2.20
5/31/202312,200 shares $26.60 thousand +3.4%0.1%0.2 $2.18
5/15/202311,800 shares $25.25 thousand -3.3%0.1%0.2 $2.14
4/30/202312,200 shares $21.47 thousand -63.8%0.1%0.2 $1.76
4/15/202333,700 shares $64.03 thousand +163.3%0.2%0.7 $1.90
3/31/202312,800 shares $25.47 thousand -25.6%0.1%0.3 $1.99
3/15/202317,200 shares $31.99 thousand -51.6%0.1%0.3 $1.86
2/28/202335,500 shares $77.75 thousand -47.6%0.2%0.7 $2.19
2/15/202367,700 shares $176.70 thousand +35.4%0.4%1.2 $2.61
1/31/202350,000 shares $115.00 thousand -40.7%0.3%0.8 $2.30
1/15/202384,300 shares $182.09 thousand +28.9%0.5%1.3 $2.16
12/30/202265,400 shares $75.21 thousand +127.9%0.4%1.1 $1.15
12/15/202228,700 shares $40.47 thousand +25.3%0.2%0.5 $1.41
11/30/202222,900 shares $35.95 thousand +2.7%0.1%0.4 $1.57
11/15/202222,300 shares $40.14 thousand -0.5%0.1%0.3 $1.80
10/31/202222,400 shares $45.02 thousand -47.5%0.1%0.3 $2.01
10/15/202242,700 shares $81.34 thousand -17.3%0.3%0.7 $1.91
9/30/202251,600 shares $97.52 thousand +32.3%0.3%0.9 $1.89
Trump's gold order: the announcement they won't put on the front page (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
9/15/202239,000 shares $95.16 thousand -14.5%0.2%0.7 $2.44
8/31/202245,600 shares $98.04 thousand -9.7%0.3%0.8 $2.15
8/15/202250,500 shares $108.58 thousand -0.4%0.3%0.5 $2.15
7/31/202250,700 shares $81.63 thousand -11.1%0.3%0.5 $1.61
7/15/202257,000 shares $100.32 thousand +325.4%0.4%0.5 $1.76
6/30/202213,400 shares $23.18 thousand -68.2%0.1%0.1 $1.73
6/15/202242,100 shares $73.68 thousand -17.8%0.3%0.4 $1.75
5/31/202251,200 shares $67.07 thousand +85.5%0.3%0.4 $1.31
5/15/202227,600 shares $39.19 thousand +17.0%0.3%0.4 $1.42
4/30/202223,600 shares $39.65 thousand -60.9%0.2%0.4 $1.68
4/15/202260,300 shares $151.35 thousand +1.3%0.6%0.9 $2.51
3/31/202259,500 shares $130.90 thousand -35.0%0.6%0.8 $2.20
3/15/202291,500 shares $167.45 thousand +37.6%0.9%0.9 $1.83
2/28/202266,500 shares $123.03 thousand -26.4%0.6%0.5 $1.85
2/15/202290,300 shares $190.53 thousand -24.0%0.8%0.7 $2.11
1/31/2022118,800 shares $285.12 thousand +52.3%1.3%0.7 $2.40
1/15/202278,000 shares $188.76 thousand -41.7%N/A0 $2.42
12/31/2021133,700 shares $405.11 thousand +188.2%1.4%0.7 $3.03
12/15/202146,400 shares $110.43 thousand -16.3%0.5%0.2 $2.38
11/30/202155,400 shares $156.23 thousand -0.7%0.6%0.4 $2.82
11/15/202155,800 shares $195.86 thousand -21.9%0.6%0.4 $3.51
10/29/202171,400 shares $235.62 thousand +152.3%0.8%0.4 $3.30
10/15/202128,300 shares $96.79 thousand -41.4%0.3%0.2 $3.42
9/30/202148,300 shares $173.40 thousand -42.0%0.5%0.3 $3.59
9/15/202183,200 shares $348.61 thousand -16.6%0.9%0.3 $4.19
8/31/202199,700 shares $443.67 thousand -26.2%1.1%0.1 $4.45
8/13/2021135,100 shares $559.31 thousand -26.7%1.4%0.1 $4.14
7/30/2021184,300 shares $790.65 thousand -26.8%1.2%0.2 $4.29
7/15/2021251,700 shares $1.07 million -40.6%1.7%0.2 $4.27
6/30/2021423,600 shares $2.14 million +57.2%2.9%0.4 $5.06

DMRA Short Interest - Frequently Asked Questions

Short interest is the volume of Damora Therapeutics, Inc. Common Stock shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 1,310,364 shares of DMRA short. 2.14% of Damora Therapeutics, Inc. Common Stock's shares are currently sold short. Learn More on Damora Therapeutics, Inc. Common Stock's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DMRA shares currently have a short interest ratio of 3.4. Learn More on Damora Therapeutics, Inc. Common Stock's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.14% of Damora Therapeutics, Inc. Common Stock's floating shares are currently sold short.

Damora Therapeutics, Inc. Common Stock saw a decline in short interest in June. As of June 15th, there was short interest totaling 1,310,364 shares, a decline of 6.6% from the previous total of 1,402,988 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

2.14% of Damora Therapeutics, Inc. Common Stock's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Damora Therapeutics, Inc. Common Stock: CG Oncology, Inc. (12.58%), Legend Biotech Corporation Sponsored ADR (6.99%), Twist Bioscience Corporation (29.26%), Xenon Pharmaceuticals Inc. (4.75%), CRISPR Therapeutics AG (28.79%), Regencell Bioscience Holdings Limited (0.16%), Oruka Therapeutics, Inc. (14.95%), Amneal Pharmaceuticals, Inc. (3.00%), Travere Therapeutics, Inc. (15.12%), Grifols, S.A. (0.88%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($77.25 billion), Invesco QQQ ($51.70 billion), iShares Russell 2000 ETF ($25.75 billion), Sandisk Corporation ($23.00 billion), Western Digital Corporation ($17.29 billion), Nebius Group N.V. ($13.25 billion), SPDR S&P Biotech ETF ($10.78 billion), KLA Corporation ($10.45 billion), Salesforce Inc. ($9.71 billion), and VanEck Semiconductor ETF ($9.01 billion). View all of the most shorted stocks.

Short selling DMRA is an investing strategy that aims to generate trading profit from Damora Therapeutics, Inc. Common Stock as its price is falling. DMRA shares are trading up $2.64 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Damora Therapeutics, Inc. Common Stock occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DMRA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DMRA, twice per month. The most recent reporting period available is June, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like DMRA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:DMRA) was last updated on 6/25/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
SpaceX is offering you shares. Don't take them.
SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $...
Behind the Markets | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel